Inflammation

Resource Center

News
Research Summaries
Resources
FDA Alerts From the Journal
Insights
Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows

Research Summaries

Conference Coverage
cc
Conference Coverage
HIV Persistence Reduced After Doubling Antiretroviral Therapy in Patients
04/18/2023
Researchers evaluated the impact an intensified dose of dolutegravir had on patients living with HIV. Their research was presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2023...
04/18/2023
Research Summary
Research Summary
Noninvasive Biomarkers Can Be Used For Monitoring and Managing Ulcerative Colitis
03/22/2023
Jessica Ganga
The American Gastroenterological Association (AGA) released a set of guidelines that outlines the use of biomarkers to treat and monitor ulcerative colitis in patients.
03/22/2023
Research Summary
Research Summary
Inflammation Reduction Medications May Lower Dementia Risk in Patients With Rheumatoid Arthritis
02/27/2023
Researchers examined the association between inflammation-reducing medications and dementia risk in patients with rheumatoid arthritis.
02/27/2023
Management
Management
New Guidelines Recommend Use of JAK, PDE-4 Inhibitors for Managing Atopic Dermatitis
01/25/2023
The American Academy of Dermatology updated its guidelines on the management of atopic dermatitis and provided new treatment options based on recent evidence.
01/25/2023
Medication
Medication
A New Drug Combination Effective in Treating Urinary Tract Infections
10/26/2022
A new drug combination was found to be more effective for treating UTIs and acute pyelonephritis compared to the current standard treatment approach.
10/26/2022
Adhesive Capsulitis
Adhesive Capsulitis
Adhesive Capsulitis Linked to Specific Gene Locations
10/18/2022
Adhesive capsulitis, known as “frozen shoulder,” has a strong association with specific gene variants
10/18/2022
risk management
risk management
COVID-19 Roundup: Variant Component in Boosters, Damage to Cardiac Muscle, Hypertension Risk
08/15/2022
In this COVID-19 roundup, coverage includes the addition of an Omicron variant component to future vaccine boosters, the relationship between a COVID-19 infection and damage to heart muscle, and how...
08/15/2022
Inflammation
Inflammation
FDA Approves First and Only Subcutaneous Option for CIDP
03/16/2018
The US Food and Drug Administration approved the drug after trials showed a lower rate of relapse in chronic inflammatory demyelinating polyneuropathy or withdrawal for any other reason.
03/16/2018
FDA ALERT
fda
FDA ALERT
FDA Approves Interchangeable Biosimilar for Psoriatic Arthritis, Other Inflammatory Conditions
11/08/2015
Anthony Calabro, MA
The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.
11/08/2015